Close
0
You have no items in your order cart.
Search
Filters

Pig & Poultry Vaccines

View as Grid List
Sort by
Display per page

Porcilis Ery+Parvo+Lepto - 20ml

149874
Erysipelas, parvovirosis and leptospirosis are widely spread infectious diseases that impact animal welfare and cause considerable losses to pig producers. Parvovirosis and leptospirosis are especially important for breeding units as they affect the sow fertility and development of pregnancy. Leptospirosis is also an important zoonosis so protecting the pig herds against it is crucial. Target species Pigs for reproduction – 2ml dose Indications for use For the active immunisation of pigs: - to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. - to reduce transplacental infection, viral load and foetal mortality caused by Porcine parvovirus. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), infection and bacterial excretion caused by L. interrogans serogroup Canicola serovar Canicola. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), severity of infection and foetal mortality caused by L. interrogans serogroup Pomona serovar Pomona. - to reduce infection caused by L. interrogans serogroup Icterohaemorrhagiae serovars Copenhageni and Icterohaemorrhagiae, L. interrogans serogroup Australis serovar Bratislava, L. kirschneri serogroup Grippotyphosa serovars Grippotyphosa and Bananal/Liangguang, L. weilii serogroup Tarassovi serovar Vughia and L. borgpetersenii serogroup Tarassovi serovar Tarassovi. Withdrawal periods Meat 0 days

Porcilis Ery+Parvo+Lepto - 50ml

149884
Erysipelas, parvovirosis and leptospirosis are widely spread infectious diseases that impact animal welfare and cause considerable losses to pig producers. Parvovirosis and leptospirosis are especially important for breeding units as they affect the sow fertility and development of pregnancy. Leptospirosis is also an important zoonosis so protecting the pig herds against it is crucial. Target species Pigs for reproduction – 2ml dose Indications for use For the active immunisation of pigs: - to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. - to reduce transplacental infection, viral load and foetal mortality caused by Porcine parvovirus. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), infection and bacterial excretion caused by L. interrogans serogroup Canicola serovar Canicola. - to reduce clinical signs (increase of body temperature and reduction in feed intake or activity), severity of infection and foetal mortality caused by L. interrogans serogroup Pomona serovar Pomona. - to reduce infection caused by L. interrogans serogroup Icterohaemorrhagiae serovars Copenhageni and Icterohaemorrhagiae, L. interrogans serogroup Australis serovar Bratislava, L. kirschneri serogroup Grippotyphosa serovars Grippotyphosa and Bananal/Liangguang, L. weilii serogroup Tarassovi serovar Vughia and L. borgpetersenii serogroup Tarassovi serovar Tarassovi. Withdrawal periods Meat 0 days

Porcilis Glasser - 50ml

107261
Porcilis Glasser is a vaccine used for active immunisation of pigs to reduce typical lesions of Glässer’s disease caused by Haemophilus parasuis serotype 5.The vaccine is of benefit when animals with no or low levels of antibodies against H. parasuis serotype 5 are mixed with pigs from or in an environment with a high prevalence of Glässer’s disease.

Porcilis Lawsonia - 100ml - Solvent

153494
Porcine proliferative enteritis is a common diarrhoeal disease of growing-finishing and young breeding pigs characterized by hyperplasia and inflammation of the ileum and colon. Target species Pigs – 2ml dose Indications for use For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection. Onset of immunity: 4 weeks after vaccination Duration of immunity: 21 weeks after vaccination Withdrawal period Meat 0 hours

Porcilis Lawsonia - 50Dose

153484
Porcine proliferative enteritis is a common diarrhoeal disease of growing-finishing and young breeding pigs characterized by hyperplasia and inflammation of the ileum and colon. Target species Pigs – 2ml dose Indications for use For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection. Onset of immunity: 4 weeks after vaccination Duration of immunity: 21 weeks after vaccination Withdrawal period Meat 0 hours

Porcilis M Hyo - 100ml

106351
An inactivated bacterial vaccine for the immunization of pigs to reduce pulmonary lesions caused by Mycoplasma hyopneumoniae infection. Contains whole cell concentrate of Mycoplasma hyopneumoniae strain 11 suspended in Diluvac Forte. VPA 10996/196/001.

Porcilis M Hyo ID Once - 100 Dose

131964
Porcilis M HYO ID ONCE is an inactivated bacterial vaccine containing whole cell concentrate of Mycoplasma hyopneumoniae strain 11. Target species Pigs (finishing pigs) Indications for use For the active immunisation of finishing pigs to reduce pulmonary lesions and the decrease in daily weight gain during the finishing period due to infection caused by Mycoplasma hyopneumoniae. Vaccination scheme: Intradermal administration of 0.2 ml per animal preferably at the sides of the neck or along the muscles of the back using an intradermal device. Vaccinate once from an age of 2 weeks onwards. Withdrawal periods Pigs – meat 0 days

Porcilis M Hyo ID Once - 50 Dose

131954
Porcilis M HYO ID ONCE is an inactivated bacterial vaccine containing whole cell concentrate of Mycoplasma hyopneumoniae strain 11. Target species Pigs (finishing pigs) Indications for use For the active immunisation of finishing pigs to reduce pulmonary lesions and the decrease in daily weight gain during the finishing period due to infection caused by Mycoplasma hyopneumoniae. Vaccination scheme: Intradermal administration of 0.2 ml per animal preferably at the sides of the neck or along the muscles of the back using an intradermal device. Vaccinate once from an age of 2 weeks onwards. Withdrawal periods Pigs – meat 0 days

Porcilis PCV ID - 10ml

131934
Porcilis PCV ID stimulates the development of active immunity against porcine circovirus type 2 in pigs. Target species Pigs – 2ml Indications for use For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by PCV2 infection. In addition, to reduce loss of daily weight gain and mortality associated with PCV2 infection. Onset of immunity: 2 weeks after vaccination. Duration of immunity: 23 weeks after vaccination. Withdrawal periods Pigs – meat 0 days

Porcilis PCV ID - 20ml

131944
Porcilis PCV ID stimulates the development of active immunity against porcine circovirus type 2 in pigs. Target species Pigs – 2ml Indications for use For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by PCV2 infection. In addition, to reduce loss of daily weight gain and mortality associated with PCV2 infection. Onset of immunity: 2 weeks after vaccination. Duration of immunity: 23 weeks after vaccination. Withdrawal periods Pigs – meat 0 days

Porcilis PCV M Hyo - 100ml

127464
Porcilis PCV M Hyo is used to protect pigs against two of the most important diseases in pigs porcine circovirus associated diseases and Enzootic pneumonia, caused by Mycoplasma hyopneumoniae. • Porcine circovirus type 2 (PCV2) infections can produce clinical signs such as wasting, weight loss or failure to grow, enlarged lymph nodes, difficulty in breathing, diarrhoea, pale skin and jaundice (yellowing of the skin). • Infection with the bacterium Mycoplasma hyopneumoniae in pigs is responsible for the development of enzootic pneumonia. Affected pigs have a dry cough and fail to thrive, with important consequences to their growth performance. Target species - Pigs for fattening Indications for use For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (PCV2) infection, and severity of lung lesions caused by Mycoplasma hyopneumoniae infection. To reduce the loss of daily weight gain during the finishing period in face of infections with Mycoplasma hyopneumoniae and/or PCV2 (as observed in field studies). Onset of immunity with single dose vaccination: PCV2: 2 weeks after vaccination M. hyopneumoniae: 4 weeks after vaccination. Onset of immunity with two dose vaccination: PCV2: 18 days after first vaccination M. hyopneumoniae: 3 weeks after the second vaccination. Duration of immunity (both vaccination schedules): PCV2: 22 weeks after (the last) vaccination M. hyopneumoniae: 21 weeks after (the last) vaccination Withdrawal periods - Pigs – meat 0 days

Porcilis PCV M Hyo - 200ml

127474
Porcilis PCV M Hyo is used to protect pigs against two of the most important diseases in pigs porcine circovirus associated diseases and Enzootic pneumonia, caused by Mycoplasma hyopneumoniae. • Porcine circovirus type 2 (PCV2) infections can produce clinical signs such as wasting, weight loss or failure to grow, enlarged lymph nodes, difficulty in breathing, diarrhoea, pale skin and jaundice (yellowing of the skin). • Infection with the bacterium Mycoplasma hyopneumoniae in pigs is responsible for the development of enzootic pneumonia. Affected pigs have a dry cough and fail to thrive, with important consequences to their growth performance. Target species - Pigs for fattening Indications for use For the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (PCV2) infection, and severity of lung lesions caused by Mycoplasma hyopneumoniae infection. To reduce the loss of daily weight gain during the finishing period in face of infections with Mycoplasma hyopneumoniae and/or PCV2 (as observed in field studies). Onset of immunity with single dose vaccination: PCV2: 2 weeks after vaccination M. hyopneumoniae: 4 weeks after vaccination. Onset of immunity with two dose vaccination: PCV2: 18 days after first vaccination M. hyopneumoniae: 3 weeks after the second vaccination. Duration of immunity (both vaccination schedules): PCV2: 22 weeks after (the last) vaccination M. hyopneumoniae: 21 weeks after (the last) vaccination Withdrawal periods - Pigs – meat 0 days